ECL Add to watchlist
$270.37 2.76 (-1.01%)
After Hours: $270.37 +0.00 (+0.00%)
Last updated: Apr 15, 2026 22:49
52-Week Range
$270.37
$229.39 $270.37 $309.27

Fundamentals Overview

Ecolab Inc. is in the middle of its 52-week range with premium valuation, trading relatively flat today.

Valuation premium

P/E 37 P/B 7.82 P/S 4.75

Intrinsic value (DCF)

-20.5% downside vs price

Profitability

Net margin 12.9%

Risk (Beta)

1.02 — in line vol

Earnings & growth

EPS $7.30 Rev +0.7% Profit -3.6% vs prior qtr

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Hold — 50% confidence Risk: Moderate Volatility — Beta 1.02. Diversify and only invest what you can afford to lose.

Supporting (Buy):

Analyst grade: B · Sentiment improving (2 upgrades)

Pressures (Sell):

DCF 20.5% downside vs price · 3M vs Basic Materials sector: -6.1%

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$76.36B
P/E (TTM)
37.02
EPS (TTM)
$7.30
Dividend Yield
0.54%
52-Week Range
$229.39 - $309.27
Volume vs Avg
N/A
Beta
1.02

About

Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through Global Industrial, Global Institutional & Specialty, and Global Healthcare & Life Sciences segments. The Global Industrial segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, metals and mining, power generation, pulp and paper,...
Sector: Basic Materials
Headquarters: US
Employees: 48,000
IPO Date: Jan 1957
Beta: 1.02 (More volatile than market)

Ratings & Grades at a Glance

Overall rating: B. Recent institutional grades: majority upgrades. Current institutional positions: Buy: 7, Equal Weight: 4, Neutral: 8, Outperform: 9, Overweight: 2.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $215.08; current price is $270.37. That’s a -20.5% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) 37.02
DCF value (model) $215.08 (-20.5% vs price)
PEG (TTM) N/A
P/B (TTM) 7.82
P/S (TTM) 4.75
P/FCF (TTM) 40.1
Liquidity & enterprise
Current Ratio (TTM) 1.08
Quick Ratio (TTM) 0.81
Cash Ratio (TTM) 0.12
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) 12.91%
Gross margin (TTM) 44.48%
Operating margin (TTM) 17.68%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for ECL.

Analyst Sentiment at a Glance

B Sentiment Improving
Buy 7Equal Weight 4Neutral 8Outperform 9Overweight 2
2 upgrades, 0 downgrades
Price Target Consensus
Current $270.37
Median $328.50
Consensus $324.40
Low consensus $293.00
High consensus $345.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
UBS maintain Neutral Neutral 2026-04-09
Baird maintain Outperform Outperform 2026-03-24
JP Morgan upgrade Neutral Overweight 2026-03-24
Wells Fargo maintain Equal Weight Equal Weight 2026-03-18
Evercore ISI Group maintain Outperform Outperform 2026-02-18
BMO Capital maintain Outperform Outperform 2026-02-13
Exane BNP Paribas maintain Outperform Outperform 2026-02-12
BNP Paribas maintain Outperform Outperform 2026-02-12
Stifel maintain Buy Buy 2026-02-11
UBS maintain Neutral Neutral 2026-02-11
Jefferies maintain Buy Buy 2026-02-11
Wells Fargo maintain Equal Weight Equal Weight 2026-02-11
RBC Capital maintain Outperform Outperform 2026-02-11
JP Morgan maintain Neutral Neutral 2026-02-11
Citigroup maintain Buy Buy 2026-02-11
Citigroup maintain Buy Buy 2026-01-21
Wells Fargo maintain Equal Weight Equal Weight 2026-01-14
UBS maintain Neutral Neutral 2026-01-07
Citigroup maintain Buy Buy 2025-12-18
Evercore ISI Group upgrade In Line Outperform 2025-11-03
UBS maintain Neutral Neutral 2025-10-31
JP Morgan maintain Neutral Neutral 2025-10-29
Stifel maintain Buy Buy 2025-10-29
Citigroup maintain Buy Buy 2025-10-29
Barclays maintain Overweight Overweight 2025-10-29
Wells Fargo maintain Equal Weight Equal Weight 2025-10-27
UBS maintain Neutral Neutral 2025-10-06
BMO Capital maintain Outperform Outperform 2025-09-08
Baird maintain Outperform Outperform 2025-09-05
UBS maintain Neutral Neutral 2025-08-14